- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04815447
Cardiopulmonary Fitness and Its Clinical Determinants of a Population of Childhood Cancer Survivor (ONCO-SPORT)
Cardiopulmonary Fitness and Its Clinical Determinants of a Population of Childhood Cancer Survivor: a Controlled Retrospective Study
Medical progress have made it possible to considerably improve the survival of children with an oncological disease. Currently, the survival rate increased to above 90 % in the most developed countries . This increase of childhood cancer survivors (CCS) asks us about their future and their quality of life. Assessing health related life quality , previous studies observe that in this particular population of patients, it is related to a poor physical capacity , physical activity level and many of these patients do not meet the activity level recommended by the world health organization due to fatigability and sedentary behaviours . In addition to these habits, the CCS are more susceptible to develop cardiovascular risk (CVR) leading to cardiovascular disease in adulthood and increases them mortality . Furthermore, CCS who have been experiencing hematopoietic stem cells transplantation (HSCT) are more susceptible to develop these CVR. In parallel with the common CVR, lower cardiopulmonary fitness assessed by cardiopulmonary exercise test (CPET) in the general population has been established as a major and independent CVR for cardiologic events.
Cardiopulmonary fitness assessed by maximal cardiopulmonary exercise test (CPET) allows physicians to measure metabolic response to maximal effort in a population that is known as VO2max. This domain of applied physiology permits a new way to approach the understanding of global health prognosis in chronic disease. For example, decrease of VO2max is involved in lower quality of life in patients with congenital heart disease. Cardiopulmonary exercise test for VO2max exploration has been demonstrated feasible in child patients with leukemia or other tumors after intensive chemotherapy, prior to HSCT.
Assessment of cardiopulmonary fitness in CCS is already described in previous studies, but this study aimed to compare a maximal CPET assessment on a large childhood cancer survivors cohort with healthy control, on a quite young cohort, during the oncologic follow up and find out its determinants.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
This is a controlled, monocentric, cross-sectional study conducted in a tertiary care center for oncologic disease in children (Montpellier University Hospital, France) was carried out between November 2010 and November 2020.
Two groups were identified: CCS group and control group.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Montpellier, Frankrig, 34295
- UH Montpellier
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
- CCS having been complete a full regimen for oncological disease and considered in remission at the end of treatment
- Controlled children with completely normal check-up, including physical examination, ECG, echocardiography and spirometry
Beskrivelse
Inclusion criteria for CCS group :
- aged between 5 and 25 years old,
- having been complete a full regimen for oncological disease and considered in remission at the end of treatment. Remission was considered in absence of relapse or new treatment initiated before the CPET end point.
Inclusion criteria for control group :
- children referred for a nonsevere functional symptom linked to exercise (murmur, palpitation or dyspnoea) or for a medical sports certificate.
- completely normal check-up, including physical examination, ECG, echocardiography and spirometry.
Exclusion criteria for control group:
- Children with any chronic disease, medical condition (cardiac, neurological, respiratory, muscular or renal)
- Children with any medical treatment
- Children requiring any further specialised medical consultation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
CCS group
Patients under 25 were recruited in the pediatric CPET laboratory of Montpellier University Hospital after a regular paediatric cardiology outpatient visit.
|
Control
The control group consisted in children referred for a non-severe functional symptom linked to exercise (murmur, palpitation, or dyspnoea) or for a medical sports certificate.
These children were classified in the control group only after a completely normal check-up, including physical examination, electrocardiogram, echocardiography, and spirometry.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
comparison of VO2max for CCS patients compared to control children
Tidsramme: 1 day
|
comparison of the mean of VO2max value in ml/kg/min between CCS group and control group
|
1 day
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
comparison of ventilatory anaerobic threshold (VAT) for CCS patients compared to control children
Tidsramme: 1 day
|
comparison of the mean of VAT value in ml/kg/min between CCS group and control group
|
1 day
|
correlation between clinical determinants and VO2max in the CCS group
Tidsramme: 1 day
|
with multivariate analysis, we will look for the correlation between the clinical determinants and the decreased of VO2max in CCS group.
|
1 day
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Arthur GAVOTTO, University Hospital, Montpellier
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- RECHMPL20_0089
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Barnekræft
-
National Cancer Institute (NCI)AfsluttetUbehandlet Childhood Brain Stem Gliom | Ubehandlet anaplastisk astrocytom i barndommen | Ubehandlet Childhood Anaplastisk Oligodendrogliom | Ubehandlet Kæmpecelle Glioblastom fra børn | Ubehandlet Childhood Glioblastom | Ubehandlet Childhood Gliomatosis Cerebri | Ubehandlet Childhood Gliosarcoma | Ubehandlet...Forenede Stater
-
Hospices Civils de LyonIkke rekrutterer endnuEarly Childhood Caries (ECC)Frankrig
-
Erik MittraNational Cancer Institute (NCI)AfsluttetUbehandlet Childhood Brain Stem Gliom | Anaplastisk ependymom hos voksne | Voksen Anaplastisk Oligodendrogliom | Voksen diffust astrocytom | Voksen kæmpecelleglioblastom | Voksen glioblastom | Gliosarkom hos voksne | Voksen blandet gliom | Voksen Oligodendrogliom | Voksen pilocytisk astrocytom | Adult Pineal... og andre forholdForenede Stater
-
National Cancer Institute (NCI)AfsluttetGlioblastom | Gliosarkom | Anaplastisk astrocytom | Ubehandlet Childhood Brain Stem Gliom | Kæmpecelleglioblastom | Ubehandlet anaplastisk astrocytom i barndommen | Ubehandlet Kæmpecelle Glioblastom fra børn | Ubehandlet Childhood Glioblastom | Ubehandlet Childhood Gliosarcoma | Hjernestamgliom | Ubehandlet barndoms... og andre forholdForenede Stater
-
National Cancer Institute (NCI)AfsluttetAnaplastisk storcellet lymfom, ALK-positivt | Ann Arbor Stage II Nonkutan Childhood Anaplastisk Storcellet Lymfom | Ann Arbor Stage III Nonkutan Childhood Anaplastisk Storcellet Lymfom | Ann Arbor Stage IV Nonkutan Childhood Anaplastisk Storcellet LymfomForenede Stater
-
Institut National de la Santé Et de la Recherche...Afsluttet
-
University of UtahJazz Pharmaceuticals; Alternating Hemiplegia of Childhood FoundationAfsluttetAlternerende Hemiplegia of ChildhoodForenede Stater
-
Assistance Publique - Hôpitaux de ParisIkke rekrutterer endnuAlternerende Hemiplegia of ChildhoodFrankrig
-
Sue O'DorisioNational Cancer Institute (NCI); Ride for KidsTrukket tilbageTilbagevendende medulloblastom i barndommen | Tilbagevendende Childhood Ependymoma | Ubehandlet Childhood Brain Stem Gliom | Ubehandlet medulloblastom i barndommen | Ubehandlet Childhood Supratentorial Primitiv Neuroectodermal Tumor | Anaplastisk astrocytom hos voksne | Anaplastisk ependymom hos voksne og andre forholdForenede Stater
-
University Hospital, BrestRekrutteringPsykotisk lidelse | Psykose af Childhood BorderlineFrankrig